APGE - Apogee Therapeutics, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 47.25

Open

Bid

$ 47.31 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 14.19 - $ 72.29

Volume

225,530

Average Volume

Market Cap

2.76B

Beta (5Y Monthly)

$ 1.78

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-05-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-28-2023	06-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Apogee Therapeutics Has Initiated Dosing O...
08/19/2024 11:02:07

Apogee Therapeutics Reported Q2 Net Loss O...
08/12/2024 10:37:23

Net Loss: Net loss for the second quarter of 2024 was $33.8 million, compared to the net loss for the second quarter of 2023 wh...

xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

XPeng & QuantumScape Are Among Top 11 Mid ...
07/14/2024 17:22:37

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

methode-electronics-posts-strong-sales-joins-quantumscape-ribbon-communications-and-other-big-stocks-moving-higher-on-thursday

Methode Electronics Posts Strong Sales, Jo...
07/11/2024 14:10:16

Apogee Doses First Patient In Phase 2 Atop...
05/15/2024 20:18:55

Interim clinical data from APG777 Phase 1 healthy volunteers study exceeded all trial objectives and achieved a half-life of ap...

Apogee Therapeutics Advances in Clinical T...
05/13/2024 11:12:19

Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company advancing differentiated biologics for the trea...

B of A Securities Initiates Coverage On Ap...
05/10/2024 10:50:42

B of A Securities analyst Geoff Meacham initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Buy rating and announ...

Apogee Therapeutics Has Dosed First Partic...
03/25/2024 11:08:07

top-3-health-care-stocks-that-are-ticking-portfolio-bombs

Top 3 Health Care Stocks That Are Ticking ...
03/14/2024 12:57:27

As of March 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum a...

Reported Earlier, Apogee Therapeutics Pric...
03/08/2024 07:52:25

The aggregate gross proceeds to Apogee from the offering are expected to be approximately $420.0 million before deducting unde...

Jefferies Maintains Buy on Apogee Therapeu...
03/06/2024 14:38:40

Jefferies analyst Akash Tewari maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target from $37 t...

Apogee Therapeutics Announces Commencement...
03/05/2024 21:30:45

Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for...

Apogee Therapeutics Files For Offering Of ...
03/05/2024 21:18:21

Crude Oil Down 1%; Dave Shares Jump After ...
03/05/2024 19:11:52

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 350 points on Tuesday. The Dow traded do...

Stifel Maintains Buy on Apogee Therapeutic...
03/05/2024 18:31:47

Stifel analyst Akash Tewari maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target from $46 to $95.

why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why SOPHiA GENETICS Shares Are Trading Low...
03/05/2024 18:11:47

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

Guggenheim Maintains Buy on Apogee Therape...
03/05/2024 17:53:32

Guggenheim analyst Seamus Fernandez maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target from ...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
03/05/2024 17:33:15

nasdaq-down-250-points-ism-services-pmi-falls-in-february

Nasdaq Down 250 Points; ISM Services PMI F...
03/05/2024 17:05:40

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow tr...

why-is-atopic-dermatitis-focused-apogee-therapeutics-stock-trading-higher-on-tuesday

Why Is Atopic Dermatitis-Focused Apogee Th...
03/05/2024 17:00:06

Apogee Therapeutics unveils promising Phase 1 data for APG777, a lead candidate for atopic dermatitis treatment. Interim result...